A groundbreaking innovation offering synchronized pacing for both heart chambers without traditional leads, transforming treatment for millions of cardiac patients

一项突破性的创新，为两个心腔提供无传统导线的同步起搏，彻底改变数百万心脏病患者的治疗方式。

In a landmark development that is set to redefine cardiac rhythm management, Abbott, a global leader in healthcare technology, has announced the launch of the world’s first dual-chamber leadless pacemaker in India. This medical breakthrough represents a major stride toward minimally invasive cardiac care, combining advanced science with patient-centric innovation..

在一项将重新定义心脏节律管理的里程碑式进展中，全球医疗技术领导者雅培公司宣布在印度推出世界上首款双腔无导线起搏器。这一医学突破代表着向微创心脏护理迈出了重要一步，将先进科学与以患者为中心的创新相结合。

This cutting-edge device is the first of its kind to provide synchronized pacing of both the right atrium and right ventricle, effectively recreating the heart’s natural rhythm without the need for traditional wires (leads) or a surgical pocket. The dual-chamber functionality marks a transformative evolution from earlier single-chamber leadless pacemakers, offering superior therapeutic outcomes, improved comfort, and a reduced risk of complications..

这款尖端设备是首个能够同步起搏右心房和右心室的同类产品，无需传统导线（电极）或手术囊袋即可有效重建心脏的自然节律。双腔功能标志着从早期单腔无导线起搏器的革命性进步，提供了更优的治疗效果、更高的舒适度，并降低了并发症风险。

“With the introduction of the world’s first dual-chamber leadless pacemaker, Abbott continues to set new standards in cardiac care,” said. “This innovation delivers the benefits of physiological pacing while eliminating the risks associated with leads and pockets. It reflects Abbott’s commitment to advancing cardiovascular health through science, precision, and compassion.”.

“随着全球首款双腔无导线起搏器的推出，雅培再次在心脏护理领域树立了新标准。” 该创新实现了生理性起搏的优势，同时消除了导线和囊袋相关的风险。这体现了雅培通过科学、精准和关怀推动心血管健康发展的承诺。

Transforming the Future of Heart Rhythm Therapy

改变心律治疗的未来

Cardiac arrhythmias, particularly bradycardia (abnormally slow heart rhythms), affect millions of people worldwide, often requiring lifelong pacing support. Traditional pacemakers, while effective, involve surgically implanted leads that connect to the heart components that can sometimes pose risks such as infections, fractures, or dislodgement..

心律失常，尤其是心动过缓（异常缓慢的心律），影响着全世界数百万人，常常需要终生起搏支持。传统的起搏器虽然有效，但需要通过手术植入与心脏相连的导线，这些导线有时会带来感染、断裂或移位等风险。

Abbott’s dual-chamber leadless pacemaker represents a next-generation solution. Each component of the system — a miniaturized device for the right atrium and another for the right ventricle communicates wirelessly through advanced synchronization technology, ensuring that both chambers beat in harmony.

雅培的双腔无导线起搏器代表了下一代解决方案。系统的每个组件——一个用于右心房的微型装置和另一个用于右心室的装置——通过先进的同步技术进行无线通信，确保两个心腔和谐跳动。

This technology mirrors the natural rhythm of a healthy heart while minimizing procedural invasiveness..

该技术在最小化手术侵入性的同时，模拟健康心脏的自然节律。

“This innovation is a game-changer for the future of cardiac rhythm management,” said. “By removing leads and surgical pockets, we are offering patients a safer, more comfortable, and long-lasting solution. It is particularly valuable for elderly patients or those with complex medical histories.”

“这一创新将改变未来心脏节律管理的游戏规则，”他说。“通过去除导线和手术囊袋，我们为患者提供了一个更安全、更舒适且持久的解决方案。这对老年患者或有复杂病史的患者尤其有价值。”